How safe is direct oral anticoagulant therapy in managing atrial fibrillation in patients with chronic kidney disease?

Data access has been approved for a research study to improve our understanding of the risks and benefits associated with direct oral anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease.
The 2022 International Population Data Linkage Network Conference 2022 will be held in Edinburgh, Scotland on 7-9 September.
